The patient experience of services for thyroid eye disease in the United Kingdom: Results of a nationwide survey

European Journal of Endocrinology

Volumn 161, Issue 3, 2009, Pages 483-487

  Estcourt, Stephanie ^a   Hickey, Janis ^b   Perros, Petros ^c   Dayan, Colin ^d   Vaidya, Bijay ^a  

^a ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^b BRITISH THYROID FOUNDATION   (United Kingdom)

^c ROYAL VICTORIA INFIRMARY   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONSULTATION; CONTROLLED STUDY; DELAYED DIAGNOSIS; ENDOCRINE OPHTHALMOPATHY; FEMALE; HEALTH CARE ACCESS; HEALTH PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PATIENT REFERRAL; PATIENT SATISFACTION; PERSONAL EXPERIENCE; PLASTIC SURGERY; POSTAL MAIL; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED KINGDOM; CLINICAL TRIAL; EVALUATION; HEALTH CARE DELIVERY; INFORMATION PROCESSING; MIDDLE AGED; MULTICENTER STUDY; PSYCHOLOGICAL ASPECT; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DATA COLLECTION; FEMALE; GRAVES OPHTHALMOPATHY; GREAT BRITAIN; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUESTIONNAIRES; YOUNG ADULT;

EID: 70349250012     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0383     Document Type: Article

References (18)

1. Perros P, Neoh C & Dickinson J. Thyroid eye disease. BMJ 2009 338 b560.
2. Bartalena L & Tanda ML. Clinical practice. Graves' ophthalmopathy. New England Journal of Medicine 2009 360 994-1001.
3. Gerding MN, Terwee CB, Dekker FW, Koornneef L, Prummel MF & Wiersinga WM. Quality of life in patients with Graves' ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid 1997 7 885-889. (Pubitemid 28041663)
4. Kahaly GJ, Petrak F, Hardt J, Pitz S & Egle UT. Psychosocial morbidity of Graves' orbitopathy. Clinical Endocrinology 2005 63 395-402.
5. Terwee C, Wakelkamp I, Tan S, Dekker F, Prummel MF & Wiersinga W. Long-term effects of Graves' ophthalmopathy on health-related quality of life. European Journal of Endocrinology 2002 146 751-757. (Pubitemid 34705066)
6. Coulter I, Frewin S, Krassas GE & Perros P. Psychological implications of Graves' orbitopathy. European Journal of Endocrinology 2007 157 127-131.
7. Estcourt S, Vaidya B, Quinn A & Shepherd M. The impact of thyroid eye disease upon patients' wellbeing: a qualitative analysis. Clinical Endocrinology 2008 68 635-639.
8. Weetman AP & Wiersinga WM. Current management of thyroid-ssociated ophthalmopathy in Europe. Results of an international survey. Clinical Endocrinology 1998 49 21-28.
9. Krassas GE, Segni M & Wiersinga WM. Childhood Graves' ophthalmopathy: results of a European questionnaire study. European Journal of Endocrinology 2005 153 515-521. (Pubitemid 41556278)
10. Perros P, Baldeschi L, Boboridis K, Dickinson AJ, Hullo A, Kahaly GJ, Kendall-Taylor P, Krassas GE, Lane CM, Lazarus JH, Marcocci C, Marino M, Mourits MP, Nardi M, Orgiazzi J, Pinchera A, Pitz S, Prummel MF & Wiersinga WM. A questionnaire survey on the management of Graves' orbitopathy in Europe. European Journal of Endocrinology 2006 155 207-211. (Pubitemid 44269436)
11. Ramos HE, Diehl LA, Camacho CP, Perros P & Graf H. Management of Graves' orbitopathy in Latin America: an international questionnaire study compared with Europe. Clinical Endocrinology 2008 69 951-956.
12. Vaidya B, Williams GR, Abraham P & Pearce SH. Radioiodine treatment for benign thyroid disorders: results of a nationwide survey of UK endocrinologists. Clinical Endocrinology 2008 68 814-820.
13. Bartalena L, Baldeschi L, Dickinson A, Eckstein A, Kendall- Taylor P, Marcocci C, Mourits M, Perros P, Boboridis K, Boschi A, Currò N, Daumerie C, Kahaly GJ, Krassas GE, Lane CM, Lazarus JH, Marinò M, Nardi M, Neoh C, Orgiazzi J, Pearce S, Pinchera A, Pitz S, Salvi M, Sivelli P, Stahl M, von Arx G & Wiersinga WM. Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. European Journal of Endocrinology 2008 158 273-285.
14. Prummel MF, Bakker A, Wiersinga WM, Baldeschi L, Mourits MP, Kendall-Taylor P, Perros P, Neoh C, Dickinson AJ, Lazarus JH, Lane CM, Heufelder AE, Kahaly GJ, Pitz S, Orgiazzi J, Hullo A, Pinchera A, Marcocci C, Sartini MS, Rocchi R, Nardi M, Krassas GE & Halkias A. Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience. European Journal of Endocrinology 2003 148 491-495. (Pubitemid 36622154)
15. Sasim IV, Berendschot TT, van Isterdael C & Mourits MP. Planning health care for patients with Graves' orbitopathy. Graefe's Archive for Clinical and Experimental Ophthalmology 2008 246 1315-1321.
16. Kendall-Taylor P. Current management of thyroid-associated ophthalmopathy. Clinical Endocrinology 1998 49 11-12.
17. Wiersinga WM. Management of Graves' ophthalmopathy. Nature Clinical Practice. Endocrinology and Metabolism 2007 3 396-404.
18. Mourits MP, Prummel MF, Wiersinga WM & Koornneef L. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clinical Endocrinology 1997 47 9-14. (Pubitemid 27313981)